CPF1 is a basic helix-loop-helix (bHLH) protein required for optimal centromere function and for maintaining methionine independent growth in yeast. In this work, we show that the region carboxy-terminal to the bHLH domain of CPF1 Is essential for CPF1 function in the cell and for dimerisation of CPF1 in solution. The C-terminus of CPF1 contains a potential long amphipathlc helix with a hydrophobic face which could provide a suitable protein:protein interface. Point mutations in residues forming this hydrophobic face are sufficient to weaken the interaction between the protein and DNA. By fusing the DNA binding domain or the transcriptlonal activation domain of GAL4 to the C-terminal 87 amino acids of CPF1, we show that this region is sufficient for mediating protein:protein interactions In vivo. The C-terminal domain of CPF1 can be replaced by the leucine repeat region of the bHLH-ZIP protein USF and the hybrid CPF1-USF protein functions In vivo to provide normal centromere function and methionine independent growth. However, the CPF1-USF hybrid protein is unable to interact with CPF1 suggesting that a dimer of CPF1 is sufficient for maintaining methionine independent growth and normal centromere function.
INTRODUCTION
The centromere and promoter factor (CPF1) binds in vivo and in vitro to the CDEI octanucleotide (RTCACRTG) found in centromeres and several promoters of genes in the budding yeast Saccharomyces cerevisiae (1) (2) (3) (4) (5) (6) (7) (8) . CPF1 contains a basic helix-loop-helix (bHLH) domain which is a DNA binding and dimerisation motif recently identified in a rapidly expanding family of proteins found in yeast, Drosophila, plants and mammals (9) (10) (11) (12) . More than 60 genes potentially encoding HLH proteins have been reported and almost every member of this class has been implicated in transcriptional regulation, oncogenesis and/or cell type determination and differentiation (for reviews see 13, 14) . One feature of some HLH proteins is their capacity to form either homodimeric or heterodimeric complexes through the HLH domain with other members of this family thereby modulating their DNA binding capacity (10, 15) . It has been suggested that the heteromers that form between the ubiquitously expressed HLH proteins (such as E12 and daughterless) and the tissue specific HLH proteins (such as myoD and achaete-scute T3) bind with higher affinity than the homodimer to the tissue-specific target sequence (CANNTG) common to the bHLH proteins thus providing the potential for a complex regulatory network for directing gene expression in eukaryotic cells (10) .
An analogous pattern of specialized protein-protein oligomerisation is also a feature of the leucine zipper transcriptional regulators (such as jun, fos and GCN4) which contain a dimerisation domain comprising an alpha-helical coiledcoil-like leucine repeat structure adjacent to a basic DNA-binding motif (16) (17) (18) (19) , for reviews see 20 -22) . A feature of the leucine zipper is the repeat of hydrophobic non-leucine residues at the 3-4 position of the heptad leucine repeat and laterally aligned charged amino acids that are proposed to effect the specificity of interactions and prevent promiscuous dimer formation (18, (23) (24) (25) . A subgroup of the bHLH proteins, the bHLH-ZIP proteins such as the myc family (N-C-L-myc and max), USF, TFE3 and AP4, also contain leucine repeat structures which function as dimerisation domains (26) (27) (28) (29) (30) .
Gene disruptions of the CPF1 locus on chromosome X result in two clear phenotypes; a partial loss of centromere function revealed by the increased rate of loss of a centromere based plasmid in strains lacking CPF1 and an absolute requirement for methionine for growth (4, 7, 8) . As duplicate CDEI motifs are found in the promoters of at least four co-regulated genes (MET25, MET2, MET3 and SAM2) whose products are involved in methionine biosynthesis, it was suggested that CPF1 might be functioning as a transcriptional regulator of this pathway (4, 7, 8, 31) . Strains of yeast containing a deletion of CPF1 extending from amino acids 10 to 209 that removes two acidic rich regions, which are a feature of many transcriptional activator proteins (32, 33, 34) , have normal centromere function and are methionine prototrophs (8) . Although CPF1 may be required, together with MET4, for activation of transcription through elements normally found in the promoters of some methionine biosynthetic genes, DNA bound CPFl is not a transcriptional activator (35) . Furthermore, strains expressing a non-DNA binding form of CPFl made by introducing a point mutation in the basic domain, are methionine prototrophs but have sub-optimal centromere function (36) . This result indicates that DNA binding of CPFl is not essential for maintaining methionine independent growth but is essential for optimal centromere function. Therefore, there may be multiple functions associated with CPFl and each function may require CPFl in a different conformation. In this paper we begin a functional analysis of CPFl and show that the protein contains an essential dimerisation domain located C-tenriinal to thebHLH. (38, 39) . 30 /ig of linear fragments containing the CPFl gene or mutant derivatives were transformed using lithium acetate into YAG90 cells at a density of no more than 5 x lOfyml. Cells were replica plated from YEPD onto defined minimal plates containing 5'FOA at 750 /tg/ml and uracil at 40 /ig/ml after 12 to 16 hours growth at 30°C. After 2 to 3 days on 5'FOA plates, the cells were replica plated back to YEPD. Strains were transformed following the procedure of Hinnen et al. to leucine prototrophy witii the CEN based plasmid pRS315 (40).
MATERIALS AND METHODS

DNA analysis
Genomic DNA was isolated from uracil auxotrophs using the method of Holm and the CPFl locus analysed by PCR using 0.1 /tg of oligonucleotides BB4357 5'CACCATGTCTCACCCAC-3' and BB4356 5'-CTCAAGCCTCATGTGG-3', 1 to 2 ^g of genomic DNA, 2.5 U of Taq Polymerase (Promega), 0.2 mM dNTPs (Pharmacia) in a total reaction volume of 100 /tl in reaction buffer provided for 38 cycles at 94°C for 90 seconds, 55 °C for 60 seconds and 72 °C for 30 seconds. The PCR product was isolated from agarose, subcloned into pSP73 and sequenced to confirm the presence of point mutations. Large deletions in the CPFl locus were detected by Southern blotting BglH cut genomic DNA.
DNA manipulations and plasmid constructions
Restriction enzymes, T4 DNA ligase and Klenow were obtained from BRL, Inc., T7-GEN in vitro mutagenesis kit and sequenase V2.0 from USB, Erase-a base kit from Promega. A SphVRsal and an PstUEcoRl fragment from CPFl on pSP73-22 were cloned into M13mpl8 as templates for mutagenesis. Radioactively labelled isotopes were obtained from Amersham International. Deletions were introduced into a CPFl fragment cloned into pGEM5Zf(+) after cutting with Nsil and BglH or Apal and Ncol and ligating a BgM linker (CAAAAGATCTTTTG). Different half molecules of CPFl were ligated together at the BglH linker and EcoRUHindm fragments used to replace the fragment in pSP73-22. Molecule 93 was made by filling-in the HindHl site at amino acid 10 and ligating it to the Hpal site located in die 3' non-coding region of CPFl. A BamW fragment (the 3 Kb fragment but containing the deletion of the open reading frame) was used to transform strain YAG90 to uracil auxotrophy. Deletion 317 was made by linking the PstVMael sites in CPFl in frame using oligonucleotides BB4943 5'-TAGATCTTTCC-TGCA-3' and BB4942 5'-GGAAAGATC-3'. Molecule 323 was created by inserting BB4711 5'-GAGATCTCTGCA-3' at the Pstl site of CPFl. Molecule 341 was made by ligating a Pstl fragment from USF containing amino acids 272 to 310 at the Pstl site of CPFl. The newly introduced amino acids at deletion end points and junctions are shown below for each molecule (number underlined). The amino acids underlined are those encoded by the linkers inserted at end points or as a result of truncations. The ten amino acids preceding and after the junctions are shown together with the position of the first and last amino acids shown.
300:
l-MNSLANNNKLKRSFATTDEWKKQR-223 309:
2O7-GRKPTTLATTAKDRSFDINTAINVLSD-247 324:
233-RRREN1NTATTKDLQIFWARAAEYIOKL-270 317:
293 Plasmid pGADlF was supplied by S.Fields (41) . Plasmid pl3H was constructed by replacing a BglR fragment, which contains a TRP1 marker on pl3T, by a BamHl fragment which contains a HIS3 marker from pMA700. Plasmid pl3T is a derivative of pKW13 carrying DNA sequences coding for the GAL4i_| 47 , which was made by replacing an £coRI///mdIII fragment with die £coRI to HindUl polylinker region of pSP73. Plasmids pl3-DD and pG-DD were constructed by cloning a BamHUBgRl fragment, which contains DNA sequences coding for CPFl^.j,, from pSP73-DD, into the BamYO. site of pl3H and pGADlF, respectively. In these two constructs CPF1 266 _3JI was inserted in frame with the GAL4|_i 47 and the GAL/^gg-ggi, respectively. Plasmid pSP73-DD was made by cloning a 1 Kb Xmril fragment containing DNA sequences coding for CPFl 266 _35i into the Smal site of pSP73.
Analysis of mutations in CPFl
In vitro transcription and translation, nuclear protein preparations, band shift analysis, growth rate analysis and the mitotic stability assay were carried out as described earlier (36) .
Cross-linking with dimethylsuberimidate (DMSI)
This method was adapted from diat published by Hu et al. (23 Figure 1 ). To assess the phenotypes associated with mutations in CPFl in vivo, the technique of gene replacement together with 5'-fluoro-orotic acid (FOA) selection was used to target the mutated versions of the CPFl gene into the CPFl locus marked with the URA3 gene in strain YAG90 (38, 39) . The presence of mutations in the CPFl locus was confirmed by restriction digestion of PCR products (data not shown). We analysed the effect of a deletion of amino acids 302 to 343 at the C-terminus of CPFl in yeast strain YAG317. This strain was compared with strains YAG300, YAG3O9 and YAG324 containing deletions of the amino terminal amino acids 10 to 209, the basic domain (amino acids 217 to 237) and the HLH domain (amino acids 243 to 260) of CPFl respectively ( Figure 1 ). We had shown previously that the first 209 amino acids are dispensable for CPFl function (8) . Strain YAG300 contains a deletion of amino acids 10 to 209 of CPFl and has essentially wild type characteristics, similar to the parental strain DBY745. However, strains YAG309, YAG324 and YAG317 are methionine auxotrophs and show suboptimal centromere function, similar to strain YAG90 containing an interruption of the CPFl gene (8; Figure 1 ). These results indicate that the first 200 amino acids of CPFl are dispensable for function in vivo but that the basic region, the HLH and the carboxyterminus are all essential for CPFl function in the cell.
The C-terminus is required for dimerisation of CPFl
Studies with previous bHLH proteins indicate that the HLH domain is required for dimerisation in solution (12, 15) . We had previously shown that CPFl, purified from yeast, binds to DNA as a dimer (8) . In order to localise the dimerisation domain for CPFl and to investigate the essential function associated with the C-terminal region of the protein we produced 35 S-labelled protein by transcription and translation of mutant versions of CPFl and analysed these proteins for DNA binding and dimerisation in vitro. In order to demonstrate that dimerisation of CPFl purified from yeast does not require auxiliary factors, the original experiment (8) was repeated using the protein produced by in vitro transcription and translation of the CPFl gene and analysed by gel retardations using a 32 P labelled CDFJ oligonucleotide. The result of co-translating increasing amounts of CPFl deletion 300 (Figure 1 ) with decreasing amounts of full length CPFl RNA is shown in Figure 2 In order to map the dimerisation domain(s) a number of internal deletions and carboxy-terminai truncations of CPFl were generated by exonuclease III digestion (Figure 1 ). The ability of the mutant forms of the CPFl protein to bind to DNA was assessed by gel retardation using a CDFJ oligonucleotide ( Figure  3A, B) . Deletion of the last 9 amino acids of CPFl (molecule 312; Figure 1 
DISCUSSION
In this paper we show that the region C-terminal to the bHLH domain of CPF1 contains an essential dimerisation domain. There are four pieces of evidence to support our claim. First, deletion analysis shows that the C-terminus is required for CPF1 function in the cell ( Figure 1 ) and for dimerisation in solution and DNA binding to CDEI (Figure 3) . Second, point mutations changing leucine 306 and isoleucine 313 to methionine are sufficient to markedly reduce the efficiency of DNA binding ( Figure 6 ). Third, the C-terminus alone, when tagged to the GAL4 DNA binding and to the transcriptional activation domains is able to mediate a protein-protein interaction resulting in the activation of a reporter gene in yeast (Table 1) . Fourth, the leucine repeat dimerisation domain of USF can function in place of the Cterminal domain ( Figure 5 ). However, we have been unable to demonstrate unequivocally that this C-terminal domain is sufficient for dimerisation of CPF1 monomers. The HLH domain may be required to ensure optimal dimerisation of CPF1 but it is not essential for this function and the basic domain of CPF1 is dispensable for dimerisation. A number of point mutations in the bHLH domain of CPF1 have been made that adversely affect the ability of the protein to maintain methionine independent growth or normal centromere function but do not affect the ability of the protein to cross-link after treatment with DMSI (52) . This indicates the bHLH domain of CPF1 does not play a critical role in dimerisation.
The nature of the C-terminal dimerisation domain of CPF1 is not clear. A number of proteins that belong to the HLH family contain one or more leucine heptad repeats or zippers at the end of the second helix. In most cases this domain is required for protein dimerisation and DNA binding (e.g AP4, 28; USF, 27; TFE3, 29; c-myc/max, 30). Structural predictions indicate an alpha helix running from the loop of CPF1 at amino acid 250 to close to the end of the protein at amino acid 340 (43, 44) . Parts of this helix, between amino acids 256 and 270 (helix 2 of the HLH) and between amino acids 295 and 320 have an amphipathic nature with a hydrophobic face and a polar face (helix 2) or a hydrophobic face and a charged face (amino acids 295 and 320). These hydrophobic faces may provide protein-protein interaction domains in an analogous way to the leucine repeat in the bZIP and bHLH-ZIP proteins. A limited analysis by point mutation shows that introducing conservative changes at leucine 306 and isoleucine 313 is sufficient to markedly reduce DNA binding and dimerisation of CPF1. We chose to replace these residues by methionine so that we could distinguish between a contribution by specific residues and the requirement for a hydrophobic face for CPF1 interactions. However, substitution of leucine 306 and isoleucine 313 by a number of different hydrophobic residues is required to rule out any effect of substituting methionine at positions 306 and 313 on the protein structure. It is possible that helix 2 and the C-terminus of CPF1 form a continuous hydrophobic face for dimerisation. This might explain why deletion of the HLH region reduces the efficiency of dimerisation but point mutations have no effect on dimerisation.
From this work it appears that CPF1 may resemble the bHLH-ZIP proteins although there is no good homology to the leucine repeat in the C-terminal domain. However, the dimerisation domain of CPF1 appears to confer characteristics which are different from those seen in some bHLH-ZIP proteins. In contrast to AP4, where the leucine repeats are dispensable for DNA binding and instead serve strictly as a dimer interface, the dimerisation domain of CPF1 is absolutely required for all functions of the protein, including DNA binding. In the full length USF protein, DNA binding requires the leucine repeat but if a large amino terminal deletion of the first 180 residues is made, the leucine repeat is now no longer required for DNA binding. It is likely that this truncated version of USF binds to DNA as a monomer or that the HLH, as with AP-4, is sufficient to mediate protein:protein interactions but only in the presence of DNA. Truncating CPF1 deletion 300 (lacking amino acids 10 to 209) at the Pstl site (amino acid 302) results in a protein that is unable to bind to CDEI indicating that a dimer may be critical for recognition of the binding site and that the HLH in the absence of the amino and carboxy-terminal regions is not sufficient to mediate dimer formation even in the presence of DNA (42) . The leucine repeat in TFE3, like that of CPF1, is absolutely required for DNA binding in vitro and the HLH when separated from the leucine repeat is incapable of mediating dimer formation in the presence of DNA (29) . However, in direct contrast to CPF1, the leucine repeat alone in TFE3 is incapable of forming stable protein:protein interactions in vivo or in vitro. TFE3 is unable to form heterodimers promiscuously. We have found no evidence that CPF1 can form heterodimers with other HLH proteins in solution or in the presence of DNA. CPF1 is unable to dimerise in the presence or absence of DNA with proteins such as PHO4, c-myc and USF, all of which bind to a common DNA sequence (CACGTG; 53-58).
The essential role of the C-terminal dimerisation domain for CPF1 function in the cell can be replaced by a region of the bHLH-ZIP protein USF containing the leucine heptad repeat, indicating that a leucine zipper can function as a dimerisation domain for CPF1. We used the CPF1-USF hybrid protein 341 to ask questions about protein-protein interactions in vitro. If CPF1 exists as a heterodimer with other proteins in yeast, in the way in which the bHLH proteins c-myc and max form a heterodimer, then we would expect protein 341 to form similar interactions to the wild type protein because yeast expressing the 341 protein show wild-type phenotypes. We tested for interactions between the CPF1-USF hybrid protein and the truncated version of CPF1 on protein 300 but were unable to find any evidence for a heterodimer. This may be because of incompatibility in the dimerisation domains (a leucine repeat in USF and an unknown domain in CPF1) or because the distance from helix 2 to the dimerisation domain is different in CPF1 and the CPF1-USF hybrid (29) . CPF1 protein 323 which contains a four amino acid insertion, including a leucine, at the Pstl site at the beginning of the leucine rich hydrophobic face is able to form DNA binding heterodimers with CPF1 in vitro. As the insertion in protein 323 theoretically causes a rotation in the putative helix, it suggests that optimal alignment of the hydrophobic faces is not essential for dimerisation in solution. This preliminary analysis of the domains required for CPF1 function indicate that while CPF1 has the structure of a bHLH protein, it may reveal more complex interactions than expected for a protein of this class.
